language_icon
EN
HI

Accretion Nutraveda Share price

ANL

261.5

0.00 (0.00%)
Last updated on 2 Jun, 2026 | 16:00 IST
Today's High

00

Today's Low

00

52 Week Low

150.10

52 Week High

300.00

Zero AMC

Free Demat with Zero AMC*

Open a Free Demat Account
+ Free 1st Year AMC

Accretion Nutraveda Chart

Accretion Nutraveda Share Key Metrics

Volume
0.00
Market Cap
189.33 CR
LTQ@LTP
0@261.50
ATP
0
Var Margin
100 %
Circuit Range
248.45-274.55
Delivery %
- %
Value
0.00
ASM/GSM
No
Market Lot
1000

Summary

Accretion Nutraveda share price is ₹261.5 as of 3 Jun, 2026. The stock Accretion Nutraveda intraday movement has stayed between ₹00 and ₹00, while on a 52-week basis,Accretion Nutraveda price 52 week high is ₹300.00 & its 52 week low is ₹150.10.
In terms of trading activity, Accretion Nutraveda has recorded a volume of 0 shares, The Accretion Nutraveda has a market cap of ₹7240000 CR. The stock’s Average Traded Price (ATP) stands at ₹0.00, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 0 @ ₹261.50.
Accretion Nutraveda operates within a circuit range of ₹248.45 – ₹274.55, with a Value of ₹0.00. The Delivery Percentage for the day is -1%. Additionally, Accretion Nutraveda currently falls under the No framework, and trades with a market lot size of 1000.

Accretion Nutraveda Fundamentals

View More
P/E Ratio

0

P/B Ratio

0

Div. Yield

0

Sector P/E

69.94

Sector P/B

2.97

Sec. Div. Yield

0.55

Accretion Nutraveda Resistance and Support

Pivot 257.92

Resistance

First Resistance

265.09

Second Resistance

268.67

Third Resistance

275.84

Support

First Support

254.34

Second Support

247.17

Third Support

243.59

Accretion Nutraveda Shareholding Pattern

View More
  • 2025-26
  • 2026-27
Total Promoters
Segment
Percent

Total Promoters

73.48%

Mutual Fund

0%

Insurance

0%

Foreign Institutional Investors

1.08%

Domestic Institutional Investors

7%

Retail

18.44%

Others

0%

Total Promoters
FEB '26
73.48%
MAR '26
73.48%

Accretion Nutraveda Corporate Actions

DateAgenda
2026-05-08Audited Results

Accretion Nutraveda News

Accretion Nutraveda Ltd - 544694 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

Accretion Nutraveda Limited reported strong financial results for FY26, with net revenue growing 110% YoY to Rs.33.60 crore and net profit increasing 102.8% YoY to Rs.5.07 crore. This growth was attributed to strong demand, operational efficiencies, and expanding market presence.
May 15 2026 18:59:12

Accretion Nutraveda Ltd - 544694 - Appointment Of Internal Auditors

Accretion Nutraveda announced strong FY26 financial results, with net profit more than doubling to Rs. 5.07 crore and revenue seeing over 110% growth. The company maintained an unmodified audit opinion.
May 08 2026 19:54:17

Accretion Nutraveda Ltd - 544694 - Appointment Of Secretarial Auditors

Accretion Nutraveda announced its FY26 audited financial results, reporting a 102.8% YoY increase in net profit to Rs.5.07 crore. Total income grew 110.6% to Rs.33.72 crore, marking its first annual results since listing.
May 08 2026 19:46:55

Accretion Nutraveda Ltd - 544694 - Announcement under Regulation 30 (LODR)-Change in Management

Accretion Nutraveda's board met and approved audited financial results for the year ended March 31, 2026. The board also reconstituted its independent director positions with two resignations and two new appointments.
May 08 2026 19:41:20

Accretion Nutraveda Ltd - 544694 - Announcement under Regulation 30 (LODR)-Change in Management

Accretion Nutraveda's board met and approved audited financial results for the year ended March 31, 2026. The board also reconstituted its independent director positions with two resignations and two new appointments.
May 08 2026 19:36:14

Accretion Nutraveda Ltd - 544694 - Announcement under Regulation 30 (LODR)-Resignation of Director

Accretion Nutraveda announced the resignation of two Non-Executive Independent Directors, Mr. Arun Dash and Mr. Mahipal Singh Chouhan, citing personal commitments. Both directors also stepped down from their respective committee roles, effective May 8, 2026.
May 08 2026 19:09:06

Accretion Nutraveda Ltd - 544694 - Board Meeting Outcome for Outcome Of Board Meeting Financial Results 31St March 2026

Accretion Nutraveda board approved its audited FY26 financial results, reporting ₹33.60 crore revenue and ₹5.07 crore net profit. The board also appointed two new Independent Directors for five years each and re-appointed Secretarial Auditors.
May 08 2026 18:52:56
Read More

Accretion Nutraveda Management

NamePosition
Mayur Popatlal SojitraManaging Director
Ankurkumar PatelWhole Time Director
View More

Accretion Nutraveda Similar Stocks

No Data Found

Accretion Nutraveda FAQs

The Buying Price of Accretion Nutraveda share is 261.5 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.

To buy Accretion Nutraveda stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Accretion Nutraveda, choose your preferred order type, and place the trade.

The Price-to-earnings (P/E) ratio of Accretion Nutraveda shares is 0. You can compare it with the sector average for relative valuation.

The Price to Book (P/B) ratio Accretion Nutraveda shares is 0. Useful to assess the stock's value relative to its book value.

To assess Accretion Nutraveda’s valuation compare Sector P/E, P/B which are 69.94 & 2.97 with sector averages, along with growth rates and financial metrics.

The Market Cap of Accretion Nutraveda is 189.33 CR. It indicates the company's size category and trading liquidity.

The 52 week high and low prices of Accretion Nutraveda share price is 300.00 & 150.10. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.

Accretion Nutraveda belongs to the Healthcare sector.

Invest with Zero-Cost Demat Account

Zero AMC for First Year
Free Research Calls
₹ 0 Trade & Call Fee
Zero-Cost